Latest Developments in Global Pharmaceutical Solvent Market

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Latest Developments in Global Pharmaceutical Solvent Market

  • Chemical and Materials
  • Feb 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

  • In April 2025, AustinPx introduced the KinetiLease™ program, enabling pharmaceutical companies to lease its KinetiSol™ research-scale equipment for bioavailability enhancement in R&D labs. This initiative grants direct access to cutting-edge amorphous dispersion technology, supporting drug development for poorly soluble molecules. The program includes comprehensive training, installation, and maintenance, ensuring seamless integration into research workflows. By offering flexible leasing options, AustinPx empowers biotech firms to accelerate innovation and optimize formulation strategies

  • In May 2025, Epson launched the SureColor S8160 eco-solvent printer, a next-generation solution for high-quality printing. Designed for large-format signage, it features PrecisionCore MicroTFP printhead technology, ensuring exceptional image quality, reliability, and efficiency. The printer supports eco-friendly solvent technologies, reflecting a broader industry shift toward sustainable solutions. With low-VOC, GreenGuard Gold-certified inks, it minimizes environmental impact while delivering vibrant colors and sharp details. This innovation aligns with growing demand for greener printing technologies, influencing research and development in pharmaceutical solvents as well
  • In June 2024, Aurorium launched Haelium Pharmaceutical Solutions, a new brand dedicated to high-purity pharmaceutical ingredients. Inspired by the Old English word “hælan”, meaning “to cure”, Haelium offers high-purity buffers, reagents, solvents, extended-release coatings, and immunostimulants for therapeutic applications such as peptide and oligonucleotide production, biologics, vaccines, and oral solid dosage forms. With four cGMP manufacturing sites in North America, Aurorium reinforces its commitment to innovation and patient outcomes. This strategic expansion strengthens its global leadership in pharmaceutical solutions
  • In August 2024, Eastman introduced Eastman electronic grade isopropyl alcohol (IPA), a high-purity solvent designed for semiconductor manufacturing. As part of the EastaPure electronic chemicals line, this domestically produced IPA ensures superior quality, reliability, and contamination control. It serves as an effective wet-clean solvent in wafer fabrication and semiconductor production, supporting front-end, middle-end, and back-end processes. This launch strengthens Eastman’s presence in the high-purity solvent market, addressing growing industry demands for precision and performance in semiconductor applications
  • In December 2024, Veolia Water Technologies launched its mobile water services for the pharmaceutical, cosmetics, and life sciences sectors across Europe. This rental-based offering provides continuous, sustainable solutions for manufacturing, cleaning, and complex liquid waste management. The service includes purified water systems, pure steam generation, and advanced waste treatment technologies, ensuring compliance with European and U.S. Pharmacopeia, FDA, cGMP, and GAMP standards. Veolia’s performance-based approach optimizes water quality and resource recovery, minimizing environmental impact while supporting industry growth